Compare RGEN & GLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | GLNG |
|---|---|---|
| Founded | 1981 | 1946 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.6B |
| IPO Year | 1995 | 2002 |
| Metric | RGEN | GLNG |
|---|---|---|
| Price | $120.16 | $53.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $172.91 | $50.63 |
| AVG Volume (30 Days) | 827.6K | ★ 2.9M |
| Earning Date | 04-28-2026 | 11-21-2023 |
| Dividend Yield | N/A | ★ 1.87% |
| EPS Growth | ★ 286.96 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $141,236,000.00 | N/A |
| Revenue This Year | $14.30 | $3.14 |
| Revenue Next Year | $14.52 | $8.66 |
| P/E Ratio | $139.53 | ★ $80.48 |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $109.66 | $35.02 |
| 52 Week High | $175.77 | $56.82 |
| Indicator | RGEN | GLNG |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 57.79 |
| Support Level | $111.29 | $39.98 |
| Resistance Level | $131.81 | N/A |
| Average True Range (ATR) | 4.70 | 1.89 |
| MACD | 1.58 | -0.29 |
| Stochastic Oscillator | 79.74 | 40.71 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Golar LNG Ltd designs, converts, owns, and operates marine infrastructure for the liquefaction of natural gas and provides floating liquefied natural gas (FLNG) services. It offers solutions for gas resource holders to develop and utilize gas reserves, including stranded, associated, flared, or underutilized resources. The company's reportable segments are: i) FLNG: includes the operations of FLNG vessels and projects, and ii) Corporate and other: includes legacy shipping segment activities, vessel management, floating storage and regasification unit services for third parties. The majority of the company's revenue is derived from the FLNG segment. Geographically, it generates the maximum revenue from Cameroon.